Date  |
|
| Dec 14, 2021 |
StageZero Life Sciences Announces Formation of Scientific Advisory Board |
| Dec 13, 2021 |
StageZero Life Sciences Named a COVID-19 Travel Testing Partner for Aruba |
| Dec 10, 2021 |
StageZero Life Sciences, Ltd Announces Appointment of SRCO as Auditors |
| Dec 10, 2021 |
StageZero Life Sciences, Ltd Announces Results of Special Meeting |
| Dec 6, 2021 |
StageZero Life Sciences Offers BORDERPASS(TM) COVID-19 PCR Test Kits for Travelers |
| Nov 26, 2021 |
StageZero Life Sciences Announces Closing of CAD$4.2 Million Private Placement with Institutional Investors |
| Nov 23, 2021 |
StageZero Life Sciences Announces CAD$4.2 Million Private Placement with Institutional Investors |
| Nov 22, 2021 |
StageZero Life Sciences ARISTOTLE(R) Multi-Cancer Blood Test Now Available in Greater Toronto Area |
| Nov 19, 2021 |
StageZero Life Sciences Introduces BORDERPASS(TM) COVID-19 PCR Testing for Travelers |
| Nov 16, 2021 |
StageZero Life Sciences Announces Q3 2021 Financial Results |
| Nov 11, 2021 |
StageZero Life Sciences and Teen Cancer America Join Forces to Help Improve Outcomes for Adolescents and Young Adults with Cancer |
| Nov 9, 2021 |
StageZero Life Sciences Corporate Update |
| Nov 9, 2021 |
StageZero to Issue Q3 2021 Financial Results and Hold Conference Call on Tuesday, November 16 |
| Oct 7, 2021 |
StageZero Life Sciences Establishes On-Site Clinic for its Next-Generation Multi-Cancer Blood Test Aristotle(TM) in Richmond, Virginia |
| Sep 27, 2021 |
StageZero Life Sciences Announces Commencement of Trading on the OTCQB |
| Sep 2, 2021 |
StageZero Life Sciences Completes Acquisition of the Health Clinics Business |
| Aug 17, 2021 |
StageZero Life Sciences Announces Q2 2021 Financial Results and Operational Update |
| Aug 16, 2021 |
StageZero Life Sciences Signs Definitive Agreement with Health Clinics Limited |
| Aug 11, 2021 |
StageZero to Issue Q2 2021 Financial Results and Hold Conference Call on Tuesday, August 17 |
| Aug 3, 2021 |
StageZero Life Sciences Appoints Matthew J. Pietras as CFO and COO |
| Jul 29, 2021 |
StageZero Life Sciences Provides Update on Planned Acquisition of Health Clinics Limited |
| Jul 12, 2021 |
StageZero Life Sciences Announces New Ticker Symbol for OTC Markets |
| Jun 30, 2021 |
StageZero Life Sciences Announces Results of Annual and Special Meeting |
| Jun 29, 2021 |
StageZero Life Sciences' Annual and Special Meeting Update Presentation Will Be Available Post Meeting |
| Jun 2, 2021 |
StageZero Life Sciences Offers Drive-Up, COVID-19 PCR Travel Testing with Results Reported the Same Day |
| May 17, 2021 |
StageZero Life Sciences Announces Q1 2021 Financial Results and Operational Update |
| May 12, 2021 |
StageZero to Issue Q1 2021 Financial Results and Hold Conference Call on Monday, May 17 |
| May 11, 2021 |
StageZero Life Sciences Announces Rexall as Retailer for COVID-19 Saliva Test Kits Throughout Canada |
| May 5, 2021 |
StageZero Life Sciences to Offer COVID-19 Saliva Test Kits Throughout Canada |
| Apr 19, 2021 |
StageZero Life Sciences to Present at the Planet MicroCap Showcase: VIRTUAL on Thursday April 22, 2021 |
| Apr 5, 2021 |
StageZero Life Sciences Introduces Aristotle, The First Multi-Cancer Test From A Single Sample of Blood |
| Apr 1, 2021 |
StageZero Life Sciences Announces Q4 2020 and Year End Financial Results and Operational Update |
| Apr 1, 2021 |
StageZero Life Sciences Announces Signed Letter of Intent for the Acquisition of Health Clinics Limited |
| Mar 31, 2021 |
StageZero Announces 2020 Year End Analyst and Investor Call |
| Jan 6, 2021 |
StageZero Life Sciences to Present at the SNN Network Canada Virtual Event on Thursday, January 7, 2021 |
| Dec 31, 2020 |
StageZero Life Sciences, Ltd Announces Appointment of New Auditors |
| Dec 7, 2020 |
StageZero Announces Third Quarter Analyst and Investor Call |
| Dec 4, 2020 |
StageZero Life Sciences Ltd. Announces Closing of Public Offering for Proceeds of $7.2 million |
| Dec 2, 2020 |
StageZero Life Sciences Announces Initiation of Testing for Travel to China |
| Nov 27, 2020 |
StageZero Life Sciences Announces Issuance of Receipt for Final Prospectus and Conditional Listing Approval |
| Nov 26, 2020 |
StageZero Life Sciences Announces Filing of Reviewed Q3 Statements |
| Nov 23, 2020 |
StageZero Life Sciences Provides Operational Update |
| Nov 20, 2020 |
StageZero Life Sciences Announced Q3, 2020 Financial Results and Operational Update |
| Nov 17, 2020 |
StageZero Life Sciences Ltd. Provides Update on Financial Statements |
| Nov 13, 2020 |
StageZero Life Sciences Named as COVID-19 Testing Partner for Barbados; Will Provide Rapid Testing Services for Travelers from U.S. and Canada |
| Oct 8, 2020 |
StageZero Life Sciences Launches Saliva PCR Testing for the Detection of the SARS-CoV-2 Virus |
| Sep 18, 2020 |
StageZero Life Sciences Announces Share Consolidation Completion |
| Sep 8, 2020 |
StageZero Life Sciences Announces Share Consolidation |
| Aug 18, 2020 |
StageZero Life Sciences Announces Results of Annual and Special Meeting |
| Aug 17, 2020 |
StageZero Life Sciences Announces Q2 2020 Progress Update |
| Aug 14, 2020 |
StageZero Announces Second Quarter Analyst and Investor Call |
| Jul 2, 2020 |
StageZero Life Sciences Announces Corporate Update |
| Jun 29, 2020 |
StageZero Life Sciences Ltd. Announces Closing of Public Offering for Proceeds of $4.6 million |
| Jun 23, 2020 |
StageZero Life Sciences Announces Issuance of Receipt for Final Prospectus and Conditional Listing Approval |
| Jun 18, 2020 |
StageZero Life Sciences Ltd. Files Amended and Restated First Quarter Financial Statements and Management Discussion and Analysis |
| Jun 1, 2020 |
StageZero Life Sciences Announces Q1 2020 Progress Update |
| May 20, 2020 |
StageZero Life Sciences Announces a Delay in its Q1 Filings |
| May 20, 2020 |
StageZero Life Sciences Announces Q4 and Full Year 2019 Results and Provides Progress Update |
| May 19, 2020 |
StageZero Life Sciences Partners with UDoTest to Link Physicians and Their Patients to Urgent COVID-19 Testing |
| May 19, 2020 |
CORRECTION: StageZero Announces Fourth Quarter 2019 Results and Year End Investor Call |
| May 15, 2020 |
CORRECTION: StageZero Announces Fourth Quarter 2019 Results and Year End Investor Call |
| May 13, 2020 |
StageZero Announces Fourth Quarter 2019 Results and Year End Investor Call |
| May 12, 2020 |
StageZero Life Sciences Announces Completion of the Convertible Security Funding Agreement with LIND |
| May 4, 2020 |
StageZero Life Sciences Announces Enhanced Relationship with Phleb-Finders |
| May 1, 2020 |
StageZero Life Sciences Provides an Update on Testing for COVID-19 In the USA. |
| Apr 20, 2020 |
StageZero Life Sciences Initiates Testing for COVID-19 In the USA |
| Apr 3, 2020 |
Amended Press Release: StageZero Life Sciences Financials Update |
| Apr 3, 2020 |
StageZero Life Sciences Announces Publication of Abstract at American Society of Clinical Oncology |
| Mar 31, 2020 |
StageZero Life Sciences preparing to offer COVID-19 testing in the U.S. and Canada |
| Mar 31, 2020 |
StageZero Life Sciences Financials Update |
| Mar 24, 2020 |
StageZero Life Sciences to Present Virtually at the Spring Investor Summit on March 25th-26th |
| Mar 18, 2020 |
StageZero Life Sciences to Present at the New York City based Investor Summit on March 25th-26th. |
| Feb 21, 2020 |
StageZero Life Sciences Announces Closing of Convertible Debenture Financing |
| Jan 30, 2020 |
StageZero Life Sciences to participate in Mercer’s new vendor database in the U.S. |
| Jan 27, 2020 |
StageZero Life Sciences Announces Closing of Financing |
| Jan 13, 2020 |
StageZero Life Sciences Retains Fig House Communications to Manage Investor Relations Activities |
| Jan 3, 2020 |
StageZero Life Sciences Announces Conversion of December 2016 Convertible Debentures |
| Dec 9, 2019 |
StageZero Life Sciences Adds BreastSentry and Prostate Health Index to Licensing and Services Agreement with Oncore Pharma |
| Nov 15, 2019 |
StageZero Life Sciences Announces Q3 2019 Progress Update |
| Nov 14, 2019 |
StageZero Life Sciences Expands Telehealth Presence With the Addition of New Partners Including an e-Commerce Platform and Expansion of In-Home Mobile Phlebotomy |
| Nov 13, 2019 |
StageZero Announces 3rd Quarter 2019 Investor Call |
| Nov 6, 2019 |
StageZero Life Sciences Makes ColonSentry(R) Blood Test Available to Consumers Through Online Telehealth Platform |
| Oct 21, 2019 |
StageZero Life Sciences Enters European Market with Oncore Pharma and BodyCheck NL: Update to Clarify Details Within the Agreement |
| Oct 10, 2019 |
StageZero Life Sciences Enters European Market with Oncore Pharma and BodyCheck NL; Multi-Year Agreement Valued at US$40 million |
| Oct 2, 2019 |
StageZero Life Sciences Direct to Consumer Marketing Campaign for Prostate Cancer Awareness Month Attracts Thousands of Responses |
| Sep 12, 2019 |
StageZero Life Sciences to Present at the Fall Investor Summit on September 16th-17th in New York City |
| Aug 14, 2019 |
StageZero Life Sciences Announces Q2 2019 Progress Update |
| Aug 12, 2019 |
StageZero Announces 2nd Quarter 2019 Investor Call |
| Aug 7, 2019 |
StageZero Life Sciences to Present at ii6 Summit in Toronto |
| Jul 26, 2019 |
StageZero Life Sciences Announces Second Closing of CDN $3.7 Million Private Placement |
| Jul 11, 2019 |
StageZero Life Sciences Announces First Closing of CDN $3.7 Million Private Placement |
| Jul 9, 2019 |
StageZero Life Sciences Expands Salesforce Through Collaboration with Coastal Medical |
| Jun 26, 2019 |
StageZero Life Sciences Ltd Announces Initiation Of Trading Under The Stock Trading Symbol SZLS |
| Jun 20, 2019 |
GeneNews Announces Results of Annual and Special Meeting of Shareholders |
| Jun 17, 2019 |
GeneNews Will Host an Investor Call and Webcast on June 19th Following the Company's Annual General Meeting |
| Jun 10, 2019 |
GeneNews Signs Global Licensing and Services Agreement with Oncore Pharma |
| May 16, 2019 |
GeneNews Announces Q1 2019 Results and Provides Progress Update |
| May 14, 2019 |
Gary the Prostate, GeneNews' Spokesperson for Prostate Cancer Awareness, Recently Diagnosed with Elevated PSA |
| May 9, 2019 |
GeneNews Introduces Gary the Prostate to Build Awareness About Prostate Health |
| Apr 22, 2019 |
The Lind Partners back GeneNews in its Quest to Detect Cancer at Stage Zero |
| Apr 17, 2019 |
The Prostate Health Index, a Blood Test for Prostate Cancer Detection, is Now Available to Consumers Nationwide Through GeneNews' National Telehealth Program |
| Apr 3, 2019 |
GeneNews Announces Q4 2018 Results and Provides Progress Update |
| Apr 3, 2019 |
CORRECTION: GeneNews Announces Fourth Quarter 2018 Results and Year End Investor Call |
| Apr 2, 2019 |
GeneNews Closes CDN $510,000 Second Tranche of Strategic Private Placement |
| Apr 2, 2019 |
CORRECTION: GeneNews Announces Fourth Quarter 2018 Results and Year End Investor Call |
| Mar 29, 2019 |
GeneNews Announces Fourth Quarter 2018 Results and Year End Investor Call |
| Mar 28, 2019 |
GeneNews Launches First Telehealth Initiative for Patient Directed Testing |
| Mar 25, 2019 |
GeneNews Closes First Tranche of $1.0 Million Strategic Private Placement |
| Jan 28, 2019 |
GeneNews Publishes Data on ColonSentry® in Colorectal Cancer Risk Assessment |
| Nov 15, 2018 |
/C O R R E C T I O N from Source -- GeneNews Limited/ |
| Nov 15, 2018 |
GeneNews Announces Q3 2018 Results and Provides Progress Update |
| Nov 13, 2018 |
GeneNews Announces Third Quarter 2018 Results Investor Call |
| Sep 24, 2018 |
GeneNews Announces Resignation of Leslie Auld as CFO and Director and Appointment of Warren Whitehead as Chief Accountant. |
| Aug 15, 2018 |
GeneNews Announces Q2 2018 Results and Provides Progress Update |
| Aug 15, 2018 |
GeneNews and LifeX™ Partner to Deliver Proprietary "Liquid Biopsy" Molecular Diagnostics to Health Systems to Detect Cancer at Earliest Stages |
| Aug 13, 2018 |
/C O R R E C T I O N from Source -- GeneNews Limited/ |
| Aug 10, 2018 |
GeneNews Second Quarter 2018 Operating and Financial Results |
| Jul 12, 2018 |
GeneNews' Innovative Diagnostic Laboratory Appoints David Byram Chief Commercial Officer |
| Jun 29, 2018 |
GeneNews Announces Election of Directors |
| May 17, 2018 |
GeneNews Announces Collaboration with AIM Laboratories to Expand Test Utilization |
| May 16, 2018 |
GeneNews Announces Q1 2018 Results and Provides Progress Update |
| May 15, 2018 |
GeneNews First Quarter 2018 Financial Results Conference Call - 8:00am Thursday, May 17, 2018 |
| Apr 3, 2018 |
GeneNews Announces Q4 and Year End 2017 Financial Results & Provides Progress Update |
| Apr 2, 2018 |
GeneNews to Report Fourth Quarter and Full Year 2017 Financial Results on April 3, 2018 - Conference Call to Follow |
| Feb 7, 2018 |
Update on Milost Equity Subscription Agreement (MESA) |
| Jan 5, 2018 |
GeneNews Announces Letter to Shareholders from CEO |
| Nov 15, 2017 |
GeneNews Announces Q3-2017 Financial Results & Provides Progress Update |
| Nov 13, 2017 |
GeneNews to Report Third Quarter 2017 Financial Results on November 15, 2017 - Conference Call to Follow |
| Nov 9, 2017 |
GeneNews Closes The $10 Million Milost Financing |
| Aug 15, 2017 |
GeneNews Announces Q2-2017 Financial Results & Provides Progress Update |
| Aug 9, 2017 |
GeneNews to Report Second Quarter 2017 Financial Results on August 15, 2017 - Conference Call to Follow |
| Jul 14, 2017 |
GeneNews Announces Extension of Warrant Exercise Incentive Program |
| Jul 14, 2017 |
GeneNews Announces Issuance of Common Shares In Lieu Of Cash Payments to Participating Members of its Board of Directors |
| Jun 30, 2017 |
GeneNews Announces Election of Directors |
| Jun 29, 2017 |
IIROC Trade Resumption - GEN |
| Jun 29, 2017 |
GeneNews Signs Binding Commitment Letter with Milost Global for US$10 Million Financing |
| Jun 29, 2017 |
IIROC Trading Halt - GEN |
| Jun 12, 2017 |
GeneNews Announces Repricing of GEM Warrants |
| May 30, 2017 |
GeneNews Early Warrant Exercise Incentive Program |
| May 15, 2017 |
GeneNews to Host IDL Business Update Conference Call on May 18, 2017 |
| May 11, 2017 |
GeneNews Announces Q1-2017 Financial Results & Provides Progress Update |
| Apr 3, 2017 |
GeneNews Announces Fourth Quarter and Full Year 2016 Financial Results |
| Mar 29, 2017 |
GeneNews Launches Blood-Based, Biomarker Test for Breast Cancer Risk Assessment |
| Mar 17, 2017 |
GeneNews Retains Marcum, LLP as New Corporate Auditor |
| Mar 16, 2017 |
GeneNews Announces Contract with Large Multi-Specialty Physician Group For Use of Early Cancer Diagnostic Tests |
| Mar 9, 2017 |
GeneNews Announces Settlement Agreement with HDL Liquidating Trust |
| Mar 7, 2017 |
GeneNews Announces Change in Auditor |
| Dec 5, 2016 |
IIROC Trade Resumption - GEN |
| Dec 2, 2016 |
GeneNews Announces Proposed Private Placement of Convertible Debentures |
| Dec 2, 2016 |
IIROC Trading Halt - GEN |
| Nov 11, 2016 |
GeneNews Announces Q3-2016 Financial Results and Provides Corporate Update |
| Oct 3, 2016 |
GeneNews Provides Update on GEM and Alumina Financings |
| Sep 19, 2016 |
Director Increases Ownership in GeneNews Limited |
| Sep 19, 2016 |
GeneNews and NueHealth Announce Partnership in Early Cancer Diagnostics |
| Sep 2, 2016 |
IIROC Trade Resumption - GEN |
| Sep 2, 2016 |
GeneNews Closes Private Placement for Approximately $1.6 Million |
| Sep 2, 2016 |
IIROC Trading Halt - GEN |
| Aug 11, 2016 |
GeneNews Announces Q2-2016 Financial Results |
| Jul 26, 2016 |
GeneNews Provides Financing Update |
| Jun 30, 2016 |
GeneNews Announces Election of Directors |
| Jun 17, 2016 |
TSX Delisting Review - GeneNews Limited (Symbol: GEN) |
| Jun 16, 2016 |
GeneNews Meets TSX Continued Listing Requirements |
| Jun 16, 2016 |
GeneNews MCTO Lifted |
| Jun 15, 2016 |
GeneNews Announces Filing of Q1-2016 Financial Results |
| Jun 9, 2016 |
GeneNews Secures CAD $5 Million Capital Commitment From GEM Global Yield Fund |
| May 27, 2016 |
GeneNews Announces Full Year 2015 Financial Results |
| May 20, 2016 |
GeneNews Issues Trading Status Clarification |
| May 19, 2016 |
GeneNews Announces a Further Extension of the TSX’s Remedial Review Process |
| May 19, 2016 |
TSX Delisting Review - GeneNews Limited (Symbol: GEN) |
| May 18, 2016 |
GeneNews Applies For Further Extension of TSX’s Remedial Review Process |
| May 11, 2016 |
GeneNews Issues MCTO Update |
| Apr 28, 2016 |
GeneNews Completes Financing under Financial Hardship Exemption |
| Apr 27, 2016 |
GeneNews Issues MCTO Update |
| Apr 12, 2016 |
GeneNews Provides Default Status Report |
| Apr 7, 2016 |
GeneNews Limited Provides Financing Update |
| Mar 31, 2016 |
GeneNews and JTS Health Partners Establish Innovative Approach to Cancer Diagnostics Through Business Acceleration Agreement |
| Mar 29, 2016 |
GeneNews Announces Granting of Management Cease Trade Order |
| Mar 17, 2016 |
GeneNews Files Management Cease Trade Order |
| Mar 16, 2016 |
GeneNews Announces Extension of TSX’s Remedial Review Process |
| Mar 16, 2016 |
TSX Delisting Review - GeneNews Limited (Symbol: GEN) |
| Mar 14, 2016 |
IIROC Trade Resumption - GEN |
| Mar 14, 2016 |
GeneNews Limited Announces Private Placement Financing of up to $5 Million |
| Mar 14, 2016 |
IIROC Trading Halt - GEN |
| Mar 11, 2016 |
GeneNews Applies For Extension of TSX’s Remedial Review Process |
| Mar 4, 2016 |
GeneNews Acquires Full Control of Innovative Diagnostic Laboratory |
| Jan 19, 2016 |
TSX Delisting Review - GeneNews Limited (Symbol: GEN) |
| Jan 18, 2016 |
GeneNews Announces Notification of TSX Continued Listing Review |
| Dec 7, 2015 |
GeneNews Provides Further Corporate Update |
| Nov 13, 2015 |
IIROC Trade Resumption - GEN |
| Nov 13, 2015 |
GeneNews Announces Q3-2015 Financial Results and Provides Update |
| Nov 13, 2015 |
IIROC Trading Halt - GEN |
| Sep 8, 2015 |
Promising Early Results of 10,000 Patient Lung Cancer Screening Trial Using EarlyCDT(R)-Lung Blood Test Announced at WCLC 2015 |
| Sep 3, 2015 |
GeneNews' Innovative Diagnostic Laboratory J-V to Provide PHI Testing Services to MD Anderson Cancer Center |
| Aug 14, 2015 |
GeneNews Announces Q2-2015 Financial Results & Provides IDL Progress Update |
| Aug 5, 2015 |
GeneNews' Innovative Diagnostic Laboratory J-V Appoints Dr. Joel V. Brill as Chief Medical Officer |
| May 19, 2015 |
GeneNews Announces Agreement to Increase IDL Ownership Stake |
| May 14, 2015 |
GeneNews Announces Q1-2015 Financial Results |
| May 13, 2015 |
GeneNews Announces Election of Directors |
| Apr 28, 2015 |
GeneNews to Present at the 2015 Bloom Burton & Co. Healthcare Investor Conference |
| Mar 31, 2015 |
GeneNews Announces Q4 and Full Year 2014 Financial Results |
| Feb 3, 2015 |
GeneNews Provides IDL Progress Update |
| Feb 3, 2015 |
GeneNews Announces Exercise of Warrants |
| Jan 2, 2015 |
GeneNews Completes Short-Form Amalgamation With Wholly-Owned Subsidiaries |
| Nov 12, 2014 |
GeneNews Reports Q3-2014 Financial Results |
| Oct 14, 2014 |
GeneNews Adds Blood Test for Breast Cancer Prediction to Innovative Diagnostic Laboratory's Offering Menu |
| Aug 8, 2014 |
GeneNews Reports Q2-2014 Financial Results |
| May 15, 2014 |
GeneNews Reports Q1-2014 Financial Results |
| May 14, 2014 |
GeneNews Announces Election of Directors |
| Apr 24, 2014 |
GeneNews' Innovative Diagnostic Laboratory J-V Launches Beckman Coulter's Prostate Health Index (phi) Across U.S. |
| Mar 4, 2014 |
GeneNews Reports Full Year and Q4 2013 Financial Results |
| Jan 21, 2014 |
GeneNews' Innovative Diagnostic Laboratory J-V Initiates U.S.-Wide Roll Out of ColonSentry(R) and Adds Important New Test to Offering Menu |
| Dec 30, 2013 |
GeneNews Limited Announces Extension of Term of Related Warrants |
| Dec 19, 2013 |
GeneNews Limited Announces Conversion of Convertible Debentures Into Common Shares |
| Dec 16, 2013 |
GeneNews Limited Announces Shareholder Approval of Conversion Opportunity for Debentureholders |
| Dec 12, 2013 |
GeneNews Limited Announces Conversion Price of Conversion Opportunity for Debentureholders |
| Dec 5, 2013 |
GeneNews Limited Debentureholders Approve Amendment to Convertible Debentures |
| Nov 14, 2013 |
GeneNews Announces Q3-2013 Financial Results, Appointment of Director and IDL Progress Update |
| Nov 13, 2013 |
GeneNews Limited Announces Conversion Opportunity for Debentureholders |
| Aug 20, 2013 |
GeneNews Announces Strategic Restructuring |
| Aug 9, 2013 |
GeneNews Reports Q2 2013 Financial Results |
| Jul 15, 2013 |
GeneNews Announces Management and Board Changes |
| Jul 2, 2013 |
GeneNews Enters Into Joint Venture to Establish US CLIA Lab |
| Jun 28, 2013 |
Leslie Auld Appointed to GeneNews Board of Directors |
| May 30, 2013 |
GeneNews Announces Election of Directors |
| May 21, 2013 |
GeneNews to Present at the Bloom Burton & Co. Healthcare Investor Conference |
| May 15, 2013 |
GeneNews Reports Q1 2013 Financial Results |
| Apr 15, 2013 |
GeneNews Announces Annual Shareholder Meeting |
| Mar 26, 2013 |
GeneNews Reports Q4 and Full Year 2012 Financial Results |
| Jan 16, 2013 |
GeneNews to Hold Shareholder Meeting |
| Dec 21, 2012 |
GeneNews Implements Share Consolidation |
| Nov 12, 2012 |
GeneNews Reports Third Quarter 2012 Financial Results |